GB0007740A
GB0007740D0
(en)
|
2000-03-31 |
2000-03-31 |
Combination therapy
|
EEP200200565A
EE200200565A
(en)
|
2000-03-31 |
2001-02-27 |
Combination therapy with vascular adverse effects
|
PT01915495T
PT1272200E
(en)
|
2000-03-31 |
2001-03-27 |
THERAPEUTICS IN FRACTIONED DOSES WITH VASCULAR DEGRADATION ACTIVITY
|
HU0300290A
HUP0300290A3
(en)
|
2000-03-31 |
2001-03-27 |
Combination therapies with vascular damaging activity
|
DE60108489T
DE60108489T2
(en)
|
2000-03-31 |
2001-03-27 |
COMBINATION THERAPIES WITH VULNERABLE ACTIVITY
|
AU2001242581A
AU2001242581B2
(en)
|
2000-03-31 |
2001-03-27 |
Combination therapies with vascular damaging activity
|
EP01915495A
EP1272200B1
(en)
|
2000-03-31 |
2001-03-27 |
Divided dose therapies with vascular damaging activity
|
AU4258101A
AU4258101A
(en)
|
2000-03-31 |
2001-03-27 |
Combination therapies with vascular damaging activity
|
MXPA02009604A
MXPA02009604A
(en)
|
2000-03-31 |
2001-03-27 |
Combination therapies with vascular damaging activity.
|
AT01915490T
ATE287267T1
(en)
|
2000-03-31 |
2001-03-27 |
COMBINATION THERAPIES WITH VASCULAR DAMAGE ACTIVITY
|
ES01915495T
ES2243466T3
(en)
|
2000-03-31 |
2001-03-27 |
DIVIDED DOSE THERAPIES WITH VASCULAR HARMFUL ACTIVITY.
|
SK1390-2002A
SK13902002A3
(en)
|
2000-03-31 |
2001-03-27 |
A vascular damaging agent, a kit comprising said agent and use of the agent
|
SI200130384T
SI1272200T1
(en)
|
2000-03-31 |
2001-03-27 |
Divided dose therapies with vascular damaging activity
|
SK1391-2002A
SK13912002A3
(en)
|
2000-03-31 |
2001-03-27 |
Combination therapies with vascular damaging activity
|
MXPA02009603A
MXPA02009603A
(en)
|
2000-03-31 |
2001-03-27 |
Divided dose therapies with vascular damaging activity.
|
CN01807444A
CN1430515A
(en)
|
2000-03-31 |
2001-03-27 |
Divided dose therapies with vascular damaging activity
|
PCT/GB2001/001317
WO2001074368A1
(en)
|
2000-03-31 |
2001-03-27 |
Combination therapies with vascular damaging activity
|
RU2002129102/14A
RU2279277C2
(en)
|
2000-03-31 |
2001-03-27 |
Therapy with divided dosages of agents of vasculodestroying activity
|
DK01915490T
DK1272199T3
(en)
|
2000-03-31 |
2001-03-27 |
Combination therapies with vascular damage activity
|
DE60111622T
DE60111622T2
(en)
|
2000-03-31 |
2001-03-27 |
ISOLATED DOSE THERAPIES WITH VULNERABLE ACTIVITY
|
US10/239,898
US20030055024A1
(en)
|
2000-03-31 |
2001-03-27 |
Divided dose therapies with vascular damaging activity
|
EEP200200549A
EE200200549A
(en)
|
2000-03-31 |
2001-03-27 |
Split dose therapy with vascular damaging activity
|
BR0109671-0A
BR0109671A
(en)
|
2000-03-31 |
2001-03-27 |
Method for producing a vascular damaging effect in a warm-blooded animal, medicament, kit, and uses of a vascular damaging agent and zd6126 or pharmaceutically acceptable salts thereof.
|
NZ534190A
NZ534190A
(en)
|
2000-03-31 |
2001-03-27 |
Divided dose therapies with vascular damaging activity
|
RU2002129097/15A
RU2268729C2
(en)
|
2000-03-31 |
2001-03-27 |
Combined therapies using of angiogenesis damaging activity
|
NZ521025A
NZ521025A
(en)
|
2000-03-31 |
2001-03-27 |
Combination and split dose therapies of ZD6126 and either a platinum anti-tumor agent, i.e. cisplatin, carboplatin oxaliplatin or ZD0473, a taxane, i.e. paclitaxel or docetaxel, or ionising radiation with vascular damaging activity
|
PT01915490T
PT1272199E
(en)
|
2000-03-31 |
2001-03-27 |
COMBINATION THERAPIES WITH LESAO VASCULAR ACTIVITY
|
CA002402078A
CA2402078A1
(en)
|
2000-03-31 |
2001-03-27 |
Divided dose therapies with vascular damaging activity
|
CZ20023228A
CZ20023228A3
(en)
|
2000-03-31 |
2001-03-27 |
Pharmaceutical preparations used for inducing blood vessel-damaging effect
|
US10/240,213
US6906048B2
(en)
|
2000-03-31 |
2001-03-27 |
N-acetylcolchinol-O-phosphate combination therapies with vascular damaging activity
|
PCT/GB2001/001329
WO2001074369A1
(en)
|
2000-03-31 |
2001-03-27 |
Divided dose therapies with vascular damaging activity
|
PL01357282A
PL357282A1
(en)
|
2000-03-31 |
2001-03-27 |
Divided dose therapies with vascular damaging activity
|
AU4258601A
AU4258601A
(en)
|
2000-03-31 |
2001-03-27 |
Divided dose therapies with vascular damaging activity
|
SI200130311T
SI1272199T1
(en)
|
2000-03-31 |
2001-03-27 |
|
CA002402539A
CA2402539A1
(en)
|
2000-03-31 |
2001-03-27 |
Combination therapies with vascular damaging activity
|
AU2001242586A
AU2001242586B2
(en)
|
2000-03-31 |
2001-03-27 |
Divided dose therapies with vascular damaging activity
|
CZ20023231A
CZ20023231A3
(en)
|
2000-03-31 |
2001-03-27 |
Pharmaceutical preparations containing blood vessel-damaging agents
|
ES01915490T
ES2236199T3
(en)
|
2000-03-31 |
2001-03-27 |
COMBINATION THERAPIES WITH VASCULAR DETERIORATION ACTIVITY.
|
BR0109672-9A
BR0109672A
(en)
|
2000-03-31 |
2001-03-27 |
Use of zd6126 or a pharmaceutically acceptable salt thereof and one of: a plantin antitumor agent and a taxane, pharmaceutical composition, combination product, kit, and method for producing a vascularly damaging effect on a warm-blooded animal
|
KR1020027013061A
KR20020087456A
(en)
|
2000-03-31 |
2001-03-27 |
Combination therapies with vascular damaging activity
|
IL15162701A
IL151627A0
(en)
|
2000-03-31 |
2001-03-27 |
Divided dose therapies with vascular damaging activity
|
JP2001572111A
JP2003528920A
(en)
|
2000-03-31 |
2001-03-27 |
Combination therapy with vascular damaging activity
|
CN01807663A
CN1422157A
(en)
|
2000-03-31 |
2001-03-27 |
Divided dose therapies with vascular damaging activity
|
HU0300576A
HUP0300576A3
(en)
|
2000-03-31 |
2001-03-27 |
Divided dose therapies with vascular damaging activity
|
IL15162801A
IL151628A0
(en)
|
2000-03-31 |
2001-03-27 |
Combination therapies with vascular damaging activity
|
DK01915495T
DK1272200T3
(en)
|
2000-03-31 |
2001-03-27 |
Divided dose therapies with blood vessel damaging activity
|
PL01366379A
PL366379A1
(en)
|
2000-03-31 |
2001-03-27 |
Combination therapies with vascular damaging activity
|
AT01915495T
ATE298240T1
(en)
|
2000-03-31 |
2001-03-27 |
SEPARATE DOSE THERAPIES WITH VASCULAR DAMAGED ACTIVITY
|
KR1020027012915A
KR20020084267A
(en)
|
2000-03-31 |
2001-03-27 |
Divided dose therapies with vascular damaging activity
|
JP2001572112A
JP2003528921A
(en)
|
2000-03-31 |
2001-03-27 |
Split-dose therapy with vascular damage activity
|
EP01915490A
EP1272199B1
(en)
|
2000-03-31 |
2001-03-27 |
Combination therapies with vascular damaging activity
|
ZA200207108A
ZA200207108B
(en)
|
2000-03-31 |
2002-09-04 |
Divided dose therapies with vascular damaging activity.
|
ZA200207114A
ZA200207114B
(en)
|
2000-03-31 |
2002-09-04 |
Combination therapies with vascular damaging activity.
|
IS6555A
IS6555A
(en)
|
2000-03-31 |
2002-09-19 |
Treatment with separate doses that have vasodilatory activity
|
IS6558A
IS6558A
(en)
|
2000-03-31 |
2002-09-20 |
Mixed disease treatment with vasoconstrictor
|
NO20024646A
NO20024646L
(en)
|
2000-03-31 |
2002-09-27 |
Combination therapies with vasculature-damaging activity
|
NO20024683A
NO20024683L
(en)
|
2000-03-31 |
2002-09-30 |
Divided dose therapies that have vascular damaging activity
|
US10/994,639
US20050107346A1
(en)
|
2000-03-21 |
2004-11-23 |
N-acetylcolchinol-o-phosphate combination therapies with vascular damaging activity
|
US11/311,618
US20070021392A1
(en)
|
2000-03-31 |
2005-12-19 |
Divided dose therapies with vascular damaging activity
|